Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PPP1R8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZBTB43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UNC93B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZCCHC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRKCG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AFF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TANC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTTNBP2NL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JUN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LETM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SENP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CORIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on